Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single and Multiple Oral BAY1101042 Tablet Doses in Healthy Male Subjects
Clinical trial NCT03252002 · COMPLETED
Trial details
- NCT number
- NCT03252002
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-16
- Primary completion
- 2019-04-30
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.